CatalystPit

JBIOJade Biosciences, Inc.

NASDAQ · PHARMACEUTICAL PREPARATIONS
Last close $14.05 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPHARMACEUTICAL PREPARATIONS
Market cap$893.54M
CountryUSA
RECENT INSIDER TRADES
  • 2025-05-19 · Frohlich Tom (Chief Executive Officer) · BUY
INSTITUTIONAL OWNERSHIP
Institutional holders156
Shares held78,104,244
Value$1.69B
Percent of shares outstanding122.81%
As of quarter end2026-06-30
RECENT NEWS
  • H.C. Wainwright reiterates Jade Biosciences stock rating at buy
  • Jade Biosciences, Inc. (JBIO) Discusses JADE301 Program Profile and Preclinical Data in Dermatomyositis - Slideshow
  • Jade Biosciences, Inc. (JBIO) Discusses JADE301 Program Profile and Preclinical Data in Dermatomyositis Transcript
  • Jade Biosciences reports preclinical data for dermatomyositis drug
  • JBIO: Jade Biosciences Announces Preclinical Data Characterizing JADE301, a Potentially Best-in-Class
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS